Quarterly Transactions Made in Madrigal Pharmaceuticals, Inc. (MDGL)
This table provides information about the institutional ownership of Madrigal Pharmaceuticals, Inc. (MDGL). The information is specifically focused on institutions that hold shares of MADRIGAL PHARMACEUTICALS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 971,776 | 524,633 | 1,496,409 | 365,547 | 769,127 | 1,134,674 | 361,735 | |
| Q4 2021 | 743,421 | 853,776 | 1,597,197 | 505,614 | 133,618 | 639,232 | 957,965 | |
| Q1 2022 | 980,076 | 403,161 | 1,383,237 | 841,745 | 321,037 | 1,162,782 | 220,455 | |
| Q2 2022 | 739,692 | 572,694 | 1,312,386 | 1,280,121 | 185,190 | 1,465,311 | -152,925 | |
| Q3 2022 | 891,240 | 431,190 | 1,322,430 | 385,509 | 11,367 | 396,876 | 925,554 | |
| Q4 2022 | 2,312,830 | 1,485,657 | 3,798,487 | 1,626,799 | 0 | 1,626,799 | 2,171,688 | |
| Q1 2023 | 1,863,757 | 1,299,290 | 3,163,047 | 2,228,329 | 0 | 2,228,329 | 934,718 | |
| Q2 2023 | 2,080,113 | 1,403,605 | 3,483,718 | 1,985,773 | 109,506 | 2,095,279 | 1,388,439 | |
| Q3 2023 | 3,357,780 | 858,227 | 4,216,007 | 1,048,327 | 117,751 | 1,166,078 | 3,049,929 | |
| Q4 2023 | 3,496,041 | 1,388,788 | 4,884,829 | 1,226,952 | 0 | 1,226,952 | 3,657,877 | |
| Q1 2024 | 3,015,458 | 1,137,001 | 4,152,459 | 2,153,142 | 0 | 2,153,142 | 1,999,317 | |
| Q2 2024 | 3,307,800 | 317,022 | 3,624,822 | 934,758 | 0 | 934,758 | 2,690,064 | |
| Q3 2024 | 995,186 | 630,187 | 1,625,373 | 885,437 | 0 | 885,437 | 739,936 | |